Blogs RIMS EDC eTMF ePRO CTMS
Clinical Research for Medical Devices: The Advantages of a TLS Approach Developing innovative medical devices requires more than a great idea. Manufacturers must navigate a landscape of strict regulations, extensive…
Reading time:6
Posted:5 June 2025
Developing innovative medical devices requires more than a great idea. Manufacturers must navigate a landscape of strict regulations, extensive testing procedures, and ongoing quality monitoring. The journey starts at the concept stage and extends far beyond market launch.
An integrated approach known as Total Lifecycle Solution (TLS) helps organizations successfully manage this complex product journey. ResearchManager supports this process with the Clinical Research Suite, specifically tailored to the MedTech sector. By using a complete solution, you avoid reinventing the wheel at each stage of medical device development.
TLS provides an integrated approach to developing medical devices through clinical research. This methodology guides the product through every stage: from initial concept and rigorous testing to market introduction and post-market surveillance once the product is in use.
The major benefit? TLS creates a clear roadmap through the maze of regulations and technical requirements. Each development phase aligns seamlessly, resulting in medical devices that are not only effective but fully compliant with current regulations.
With the Medical Device Regulation (MDR) imposing increasingly stringent demands, manufacturers can no longer afford inefficient processes. TLS ensures that innovation moves quickly without compromising compliance.
Clinical studies are crucial to the development of medical devices, especially to demonstrate safety, effectiveness, and compliance under MDR.
The MDR requires manufacturers to provide data proving their products are safe and effective.
Clinical studies ensure the product meets CE marking standards necessary for commercial use in Europe.
Manufacturers must also demonstrate how the device performs in real-world settings, not just controlled environments.
Clinical studies help identify unexpected side effects and potential risks before a device reaches the market.
Patient safety is always the top priority, and clinical trials provide evidence that the device does no harm.
In the competitive MedTech market, effectiveness is a key selling point.
If your research data shows better results than existing solutions, you immediately gain a strong market advantage.
Thorough clinical studies provide exactly these valuable comparative insights.
The work doesn’t stop at market launch. MDR mandates Post-Market Clinical Follow-up (PMCF) studies to track device performance in real-world settings.
This continuous monitoring captures long-term effects and gathers new data on safety and efficacy.
No formal clinical research yet, but preclinical testing is conducted. These early tests provide the scientific basis for future clinical evaluation.
Preclinical studies
Material and biocompatibility tests
Simulations and mechanical stress tests
Animal studies following ethical guidelines
Example:
A MedTech company developed a new wearable blood glucose sensor. During preclinical testing, they evaluated five enzyme coatings. One patented coating demonstrated 14-day stability (three times longer than similar sensors) and accurate readings across a broad glucose range—forming a strong foundation for further development.
This is when technology meets humans. The product is tested on a small group of patients to assess early real-world performance.
First-in-Human Study (FIH)
The first clinical trial involving human participants, typically a small group, to evaluate basic safety and function.
Feasibility Studies
Small-scale studies that assess whether the device can be used intuitively and effectively under real conditions.
Example:
Following preclinical success, the company conducted a feasibility study with 40 diabetes patients. The sensor showed 94% accuracy compared to finger-prick tests and was rated highly for ease of use—greenlighting broader clinical studies.
This decisive phase provides statistically significant evidence for safety and efficacy. These results form the scientific foundation for all claims and regulatory submissions.
Pivotal Study
Large-scale trials that allow for statistically valid conclusions, often conducted as Randomized Controlled Trials (RCTs) or cohort studies.
Example:
The company enrolled 280 patients in 8 hospitals across 3 countries in a pivotal RCT comparing their sensor to the market leader. After 6 months, the sensor showed 22% better accuracy, 35% less skin irritation, and improved therapy adherence. These results formed the core evidence for CE certification.
All research data is compiled and submitted to regulatory authorities. This phase bridges years of research with actual market access.
Clinical Evaluation Report (CER)
Summarizes all clinical data and demonstrates that the device is safe and effective, per MDR. Submitted to the Notified Body for CE marking.
Example:
The company compiled a comprehensive CER combining preclinical, pilot, and pivotal trial data. Their strategic collaboration with the Notified Body led to CE marking in 9 months—much faster than the industry average of 15 months for similar devices.
This phase transitions from controlled environments to real-world use. Continuous monitoring captures long-term effects and identifies new opportunities or issues.
Post-Market Clinical Follow-up (PMCF)
Ongoing tracking of the device to collect real-world data and assess long-term safety and performance.
Real-World Data Studies
Data is collected from users and physicians, often via digital surveys (ePRO) or reporting systems.
Incident Tracking
Monitoring for side effects or adverse events post-launch.
Example:
After launch, the company implemented a PMCF program using a custom app to collect data from over 12,000 patients. They discovered an 18% drop in hyperglycemic events among users, prompting an expansion of clinical indications. Continuous monitoring also detected a rare battery issue, which they proactively addressed through new research.
ResearchManager offers an all-in-one solution for managing every aspect of clinical research and product development—with real-time monitoring for instant insights into study progress, participant data, and safety reports. The platform supports each phase with user-friendly tools that comply with MDR standards.
Beyond software, ResearchManager provides expert support in implementation, process optimization, and compliance. Consultancy and training services help organizations streamline documentation, manage data efficiently, and enhance clinical operations.
This integrated approach helps manufacturers bring medical devices to market faster and safer, without compromising on quality or compliance.
Medical device development is full of challenges. From early concept to market launch, a process that’s both efficient and compliant is essential. ResearchManager provides exactly that with the Clinical Research Suite and expert consultants who optimize your workflow.
By supporting each phase of the Total Lifecycle Solution (TLS)—from early development and pilot studies to pivotal trials and post-market surveillance—ResearchManager simplifies your path to CE certification and market entry. Integrated tools like EDC, eTMF, CTMS, and eConsent boost efficiency while ensuring MDR compliance.
The result?
Faster market access without compromising safety or compliance.
Book a demo today and experience how the right software makes all the difference in your journey to market.
